End Cash: The amount of cash held by the company for the given period.
Cognition Therapeutics, Inc. (CGTX) had End Cash of $28.53M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-7.04M |
|
-- |
|
-- |
|
$14.68M |
|
$-14.68M |
|
$7.64M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-14.68M |
|
$-14.61M |
|
40.06M |
|
40.06M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$33.55M |
|
$0.23M |
|
$0.82M |
|
$34.37M |
|
$10.92M |
|
-- |
|
$0.44M |
|
$11.36M |
|
$23.01M |
|
$23.01M |
|
$23.01M |
|
40.11M |
|
| Cash Flow Statement Financials | |
$-13.24M |
|
$-0.00M |
|
$11.86M |
|
$29.92M |
|
|
End Cash |
$28.53M |
$-1.39M |
|
$2.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.60% |
|
-30.60% |
|
-20.49% |
|
-30.60% |
|
$0.57 |
|
$-0.33 |
|
$-0.33 |
|